Polθ-IN-1-d3 free base · Synonyms: Pol-Theta-IN-1-d3 | Pol-IN-1-d3
Polθ-IN-1-d3 (example 1) is a deuterated Polθ inhibitor used for cancer study (extracted from patent WO2021028670).
For research use only. Not for human or veterinary use.
Purity >98%
Stock Inquire
Polθ-IN-1-d3 structure
CAS No.: 2598122-35-9
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 5 mg | Inquire | BP-02033-5mg | Inquire | Inquire |
| 10 mg | Inquire | BP-02033-10mg | Inquire | Inquire |
Need another size or custom synthesis? Request a quote.
Description
Polθ-IN-1-d3 (example 1) is a deuterated Polθ inhibitor used for cancer study (extracted from patent WO2021028670).
Identifiers
- SMILES
-
O=C([C@H]([C@H](O)[C@@H]1O)N(C2=NC(C)=CC(C(F)(F)F)=C2)C1=O)N(C3=CC(Cl)=C(F)C=C3F)C([2H])([2H])[2H] - InChIKey
-
XDGNFDFXUBJGRV-YQCADYNBSA-N
Specifications
- MW (average)
- 482.8040
- Formula
- C19H15ClF5N3O4
- CAS No.
- 2598122-35-9
- Physical state
- Solid
- Color
- White to off-white
- Shipping
- —
- Storage
- —
Documents
References
[1].DEUTERATED COMPOUNDS FOR USE IN THE TREATMENT OF CANCER. Patent WO2021028670.